Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
236 hedge funds and large institutions have $1.2B invested in Dynavax Technologies in 2022 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 85 increasing their positions, 80 reducing their positions, and 9 closing their positions.
311% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 9
41% more call options, than puts
Call options by funds: $13.5M | Put options by funds: $9.6M
13% more funds holding
Funds holding: 209 → 236 (+27)
6% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 80
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.46% less ownership
Funds ownership: 92.98% → 91.52% (-1.5%)
18% less capital invested
Capital invested by funds: $1.46B → $1.2B (-$257M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$21.4M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$9.78M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.39M |
| 4 |
Millennium Management
New York
|
+$9.21M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$8.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$44.4M |
| 2 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$39.1M |
| 3 |
Two Sigma Investments
New York
|
-$9.68M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$9.28M |
| 5 |
Two Sigma Advisers
New York
|
-$5.04M |
DVAX Hedge Fund Activity: Q3 2022 in Review
236 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2022, worth a combined $1.2B — down 18% from $1.46B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new DVAX positions and 9 closed out — a net gain of 28 holders — while 85 added to existing stakes and 80 trimmed.
The largest buyer was State Street, adding an estimated $21.4M. The largest seller was Federated Hermes, cutting an estimated $44.4M.
- 236 institutional investors held Dynavax Technologies (DVAX) as of Q3 2022, up from 209 in Q2 2022.
- Funds reported $1.2B of Dynavax Technologies stock for Q3 2022, down 18% quarter-over-quarter.
- 37 funds opened new Dynavax Technologies positions in Q3 2022 and 9 closed out, a net change of +28 holders.
- The largest Dynavax Technologies buyer in Q3 2022 was State Street, an estimated $21.4M added.
- The largest Dynavax Technologies seller in Q3 2022 was Federated Hermes, an estimated $44.4M sold.
Based on aggregated 13F filings for Q3 2022.